Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 15 | 0 | 1 | 0 | 1 |
Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
Oxytocin receptor | 0 | 0 | 1 | 1 |
Vasopressin V1a receptor | 0 | 1 | 1 | 2 |
Vasopressin V1b receptor | 0 | 1 | 1 | 2 |
Translocator protein | 0 | 1 | 0 | 1 |
Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 5 | 0 | 0 | 5 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 1 | 0 | 0 | 1 |
glp-1 receptor, partial | 3 | 0 | 0 | 3 |
RAR-related orphan receptor gamma | 6 | 0 | 0 | 6 |
USP1 protein, partial | 5 | 0 | 0 | 5 |
GLI family zinc finger 3 | 8 | 0 | 0 | 8 |
thyroid stimulating hormone receptor | 6 | 0 | 0 | 6 |
nuclear receptor subfamily 1, group I, member 3 | 5 | 0 | 0 | 5 |
progesterone receptor | 5 | 0 | 0 | 5 |
glucocorticoid receptor [Homo sapiens] | 6 | 0 | 0 | 6 |
pregnane X nuclear receptor | 5 | 0 | 0 | 5 |
estrogen nuclear receptor alpha | 9 | 0 | 0 | 9 |
67.9K protein | 2 | 0 | 0 | 2 |
bromodomain adjacent to zinc finger domain 2B | 1 | 0 | 0 | 1 |
peroxisome proliferator-activated receptor delta | 5 | 0 | 0 | 5 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 6 | 0 | 0 | 6 |
thyroid stimulating hormone receptor | 1 | 0 | 0 | 1 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 3 | 0 | 0 | 3 |
chromobox protein homolog 1 | 3 | 0 | 0 | 3 |
potassium voltage-gated channel subfamily H member 2 isoform d | 4 | 0 | 0 | 4 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
Cathepsin B | 0 | 2 | 0 | 2 |
Cathepsin B | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-gamma | 3 | 0 | 0 | 3 |
Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
Chain A, Sex Hormone-Binding Globulin | 0 | 0 | 1 | 1 |
Chain A, HADH2 protein | 3 | 0 | 0 | 3 |
Chain B, HADH2 protein | 3 | 0 | 0 | 3 |
interleukin 8 | 3 | 0 | 0 | 3 |
AR protein | 8 | 0 | 0 | 8 |
estrogen receptor 2 (ER beta) | 4 | 0 | 0 | 4 |
retinoic acid nuclear receptor alpha variant 1 | 4 | 0 | 0 | 4 |
retinoid X nuclear receptor alpha | 5 | 0 | 0 | 5 |
estrogen-related nuclear receptor alpha | 6 | 0 | 0 | 6 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 5 | 0 | 0 | 5 |
thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 2 | 0 | 0 | 2 |
Histone H2A.x | 2 | 0 | 0 | 2 |
vitamin D3 receptor isoform VDRA | 2 | 0 | 0 | 2 |
transcriptional regulator ERG isoform 3 | 1 | 0 | 0 | 1 |
thyroid hormone receptor beta isoform 2 | 5 | 0 | 0 | 5 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 6 | 0 | 0 | 6 |
geminin | 4 | 0 | 0 | 4 |
peripheral myelin protein 22 | 4 | 0 | 0 | 4 |
cytochrome P450 3A4 isoform 1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit pi | 2 | 0 | 0 | 2 |
Voltage-dependent calcium channel gamma-2 subunit | 3 | 0 | 0 | 3 |
Plasma kallikrein | 0 | 1 | 0 | 1 |
Glucocorticoid receptor | 0 | 3 | 0 | 4 |
Sex hormone-binding globulin | 0 | 1 | 1 | 2 |
Progesterone receptor | 0 | 1 | 0 | 1 |
Progesterone receptor | 0 | 1 | 1 | 2 |
Glucocorticoid receptor | 0 | 1 | 0 | 1 |
Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
Sex hormone-binding globulin | 0 | 1 | 0 | 1 |
Androgen receptor | 0 | 2 | 2 | 6 |
Aromatase | 0 | 1 | 0 | 2 |
Androgen receptor | 0 | 4 | 1 | 5 |
Gamma-aminobutyric acid receptor subunit beta-1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit delta | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 2 | 0 | 0 | 2 |
Androgen receptor | 0 | 1 | 1 | 2 |
Glutamate receptor 2 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 2 | 0 | 0 | 2 |
Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 2 | 0 | 0 | 2 |
Testosterone 17-beta-dehydrogenase 3 | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 0 | 1 | 1 |
Cannabinoid receptor 2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-3 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-2 | 2 | 0 | 0 | 2 |
G-protein coupled bile acid receptor 1 | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor | 0 | 1 | 1 | 2 |
GABA theta subunit | 2 | 0 | 0 | 2 |
Neuropeptide FF receptor 2 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 2 | 0 | 0 | 2 |
ALK tyrosine kinase receptor | 0 | 1 | 0 | 1 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 2 | 0 | 0 | 2 |
Chain A, Dihydrofolate reductase | 0 | 0 | 1 | 1 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 3 | 0 | 0 | 3 |
Chain A, 2-oxoglutarate Oxygenase | 3 | 0 | 0 | 3 |
Chain A, Ferritin light chain | 1 | 0 | 0 | 1 |
acid sphingomyelinase | 1 | 0 | 0 | 1 |
aldehyde dehydrogenase 1 family, member A1 | 3 | 0 | 0 | 3 |
glucocerebrosidase | 3 | 0 | 0 | 3 |
alpha-galactosidase | 1 | 0 | 0 | 1 |
activating transcription factor 6 | 1 | 0 | 0 | 1 |
lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 1 | 0 | 0 | 1 |
DNA polymerase beta | 1 | 0 | 0 | 1 |
Multidrug resistance-associated protein 4 | 0 | 3 | 0 | 4 |
Bile salt export pump | 0 | 5 | 0 | 5 |
Cellular tumor antigen p53 | 5 | 0 | 0 | 5 |
Thymidylate synthase | 0 | 2 | 0 | 2 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 0 | 1 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Alpha-synuclein | 1 | 0 | 0 | 1 |
Folylpolyglutamate synthase, mitochondrial | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1A3 | 0 | 1 | 0 | 1 |
Folylpolyglutamate synthase, mitochondrial | 0 | 0 | 0 | 1 |
Multidrug resistance associated protein | 0 | 0 | 0 | 1 |
SMAD family member 2 | 3 | 0 | 0 | 3 |
SMAD family member 3 | 3 | 0 | 0 | 3 |
farnesoid X nuclear receptor | 4 | 0 | 0 | 4 |
flap endonuclease 1 | 3 | 0 | 0 | 3 |
Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
Chain A, Cruzipain | 1 | 0 | 0 | 1 |
Albumin | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
aryl hydrocarbon receptor | 2 | 0 | 0 | 2 |
cellular tumor antigen p53 isoform a | 1 | 0 | 0 | 1 |
Integrin beta-3 | 1 | 0 | 0 | 1 |
Integrin alpha-IIb | 1 | 0 | 0 | 1 |
Chain A, Beta-lactamase | 1 | 0 | 0 | 1 |
GALC protein | 2 | 0 | 0 | 2 |
TDP1 protein | 4 | 0 | 0 | 4 |
Microtubule-associated protein tau | 3 | 0 | 0 | 3 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 1 | 0 | 0 | 1 |
PINK1 | 1 | 0 | 0 | 1 |
G | 2 | 0 | 0 | 2 |
Parkin | 1 | 0 | 0 | 1 |
peroxisome proliferator activated receptor gamma | 3 | 0 | 0 | 3 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 1 | 0 | 0 | 1 |
lamin isoform A-delta10 | 3 | 0 | 0 | 3 |
Interferon beta | 2 | 0 | 0 | 2 |
HLA class I histocompatibility antigen, B alpha chain | 2 | 0 | 0 | 2 |
Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
Cytochrome P450 2C19 | 0 | 2 | 0 | 2 |
Spike glycoprotein | 3 | 0 | 0 | 3 |
Inositol hexakisphosphate kinase 1 | 2 | 0 | 0 | 2 |
cytochrome P450 2C9, partial | 2 | 0 | 0 | 2 |
Neuropeptide Y receptor type 1 | 0 | 2 | 0 | 2 |
Neuropeptide Y receptor type 2 | 0 | 2 | 0 | 2 |
acetylcholinesterase | 1 | 0 | 0 | 1 |
thioredoxin reductase | 1 | 0 | 0 | 1 |
phosphopantetheinyl transferase | 2 | 0 | 0 | 2 |
ATAD5 protein, partial | 1 | 0 | 0 | 1 |
thioredoxin glutathione reductase | 1 | 0 | 0 | 1 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 3 | 0 | 0 | 3 |
cytochrome P450 2D6 | 2 | 0 | 0 | 2 |
IDH1 | 1 | 0 | 0 | 1 |
DNA polymerase iota isoform a (long) | 1 | 0 | 0 | 1 |
DNA polymerase kappa isoform 1 | 3 | 0 | 0 | 3 |
survival motor neuron protein isoform d | 1 | 0 | 0 | 1 |
muscleblind-like protein 1 isoform 1 | 1 | 0 | 0 | 1 |
streptokinase A precursor | 0 | 0 | 1 | 1 |
lethal factor (plasmid) | 1 | 0 | 0 | 1 |
ATP-binding cassette sub-family C member 3 | 0 | 3 | 0 | 3 |
Bile salt export pump | 0 | 1 | 0 | 1 |
Estrogen receptor | 0 | 0 | 1 | 1 |
Caspase-7 | 1 | 0 | 0 | 1 |
60 kDa chaperonin | 0 | 1 | 0 | 1 |
Estrogen receptor beta | 0 | 0 | 1 | 1 |
10 kDa chaperonin | 0 | 1 | 0 | 1 |
Canalicular multispecific organic anion transporter 1 | 0 | 3 | 0 | 3 |
ATPase family AAA domain-containing protein 5 | 2 | 0 | 0 | 2 |
Ataxin-2 | 2 | 0 | 0 | 2 |
CDGSH iron-sulfur domain-containing protein 1 | 0 | 2 | 0 | 2 |
Fumarate hydratase | 1 | 0 | 0 | 1 |
GLS protein | 2 | 0 | 0 | 2 |
polyprotein | 1 | 0 | 0 | 1 |
euchromatic histone-lysine N-methyltransferase 2 | 3 | 0 | 0 | 3 |
D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
Amyloid-beta precursor protein | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M2 | 0 | 2 | 1 | 4 |
Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M1 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M3 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M2 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M1 | 0 | 2 | 0 | 3 |
Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 2 |
Sodium-dependent noradrenaline transporter | 0 | 2 | 0 | 2 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
D(3) dopamine receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
MBT domain-containing protein 1 | 0 | 1 | 0 | 1 |
Lethal(3)malignant brain tumor-like protein 4 | 0 | 1 | 0 | 1 |
Lethal(3)malignant brain tumor-like protein 3 | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
Lethal(3)malignant brain tumor-like protein 1 | 0 | 1 | 0 | 1 |
endonuclease IV | 1 | 0 | 0 | 1 |
15-lipoxygenase, partial | 1 | 0 | 0 | 1 |
nonstructural protein 1 | 1 | 0 | 0 | 1 |
arylsulfatase A | 1 | 0 | 0 | 1 |
Bloom syndrome protein isoform 1 | 1 | 0 | 0 | 1 |
peripheral myelin protein 22 isoform 1 | 1 | 0 | 0 | 1 |
cytochrome P450 2C19 precursor | 2 | 0 | 0 | 2 |
M-phase phosphoprotein 8 | 1 | 0 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
Histamine H2 receptor | 2 | 0 | 0 | 2 |
ATP-dependent phosphofructokinase | 2 | 0 | 0 | 2 |
Luciferase | 3 | 0 | 0 | 3 |
hypoxia-inducible factor 1 alpha subunit | 1 | 0 | 0 | 1 |
Caspase-7 | 1 | 0 | 0 | 1 |
caspase-3 | 1 | 0 | 0 | 1 |
heat shock protein beta-1 | 1 | 0 | 0 | 1 |
Substance-P receptor | 0 | 2 | 0 | 2 |
Neuromedin-K receptor | 0 | 0 | 1 | 1 |
Substance-K receptor | 0 | 1 | 1 | 2 |
Substance-K receptor | 0 | 2 | 0 | 2 |
Substance-P receptor | 0 | 2 | 1 | 3 |
Neuromedin-K receptor | 0 | 1 | 1 | 2 |
Substance-P receptor | 0 | 1 | 0 | 1 |
Substance-K receptor | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 0 | 1 | 1 |
Substance-K receptor | 0 | 1 | 0 | 1 |
Growth hormone secretagogue receptor type 1 | 0 | 0 | 1 | 1 |
Mas-related G-protein coupled receptor member X2 | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
thyroid hormone receptor beta isoform a | 1 | 0 | 0 | 1 |
Endothelin-1 receptor | 0 | 2 | 0 | 2 |
Endothelin-1 receptor | 0 | 1 | 0 | 1 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
regulator of G-protein signaling 4 | 1 | 0 | 0 | 1 |
EWS/FLI fusion protein | 1 | 0 | 0 | 1 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
ATP-dependent 6-phosphofructokinase | 0 | 1 | 0 | 1 |
Ectonucleoside triphosphate diphosphohydrolase 2 | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase D3 | 0 | 1 | 0 | 1 |
Protein kinase C gamma type | 0 | 1 | 0 | 1 |
Protein kinase C beta type | 0 | 1 | 0 | 1 |
Protein kinase C alpha type | 0 | 1 | 0 | 1 |
Tyrosine-protein phosphatase non-receptor type 1 | 0 | 1 | 0 | 1 |
D(3) dopamine receptor | 0 | 1 | 0 | 1 |
Protein kinase C eta type | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 0 | 1 | 1 |
Delta-type opioid receptor | 0 | 0 | 1 | 1 |
Kappa-type opioid receptor | 0 | 0 | 1 | 1 |
P2Y purinoceptor 2 | 0 | 1 | 1 | 2 |
Protein kinase C iota type | 0 | 1 | 0 | 1 |
P2X purinoceptor 1 | 0 | 0 | 1 | 1 |
P2Y purinoceptor 1 | 0 | 0 | 1 | 1 |
P2X purinoceptor 2 | 0 | 1 | 1 | 2 |
P2X purinoceptor 4 | 0 | 0 | 1 | 1 |
P2X purinoceptor 5 | 0 | 0 | 1 | 1 |
P2X purinoceptor 6 | 0 | 0 | 1 | 1 |
P2Y purinoceptor 4 | 0 | 0 | 1 | 1 |
NAD-dependent protein deacetylase HST2 | 0 | 1 | 0 | 1 |
P2X purinoceptor 3 | 0 | 0 | 1 | 1 |
DNA-dependent protein kinase catalytic subunit | 0 | 1 | 0 | 1 |
Ectonucleoside triphosphate diphosphohydrolase 1 | 0 | 1 | 0 | 1 |
Inositol monophosphatase 1 | 1 | 0 | 0 | 1 |
DNA primase | 0 | 1 | 0 | 1 |
Protein kinase C epsilon type | 0 | 1 | 0 | 1 |
Protein kinase C theta type | 0 | 1 | 0 | 1 |
Protein kinase C zeta type | 0 | 1 | 0 | 1 |
Protein kinase C delta type | 0 | 1 | 0 | 1 |
P2Y purinoceptor 6 | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase D1 | 0 | 1 | 0 | 1 |
Dual specificity protein phosphatase 5 | 0 | 1 | 0 | 1 |
Ectonucleoside triphosphate diphosphohydrolase 8 | 0 | 1 | 0 | 1 |
RmtA | 0 | 1 | 0 | 1 |
Reverse transcriptase/RNaseH | 0 | 1 | 0 | 1 |
Ectonucleoside triphosphate diphosphohydrolase 3 | 0 | 1 | 0 | 1 |
NAD-dependent protein deacetylase sirtuin-2 | 0 | 1 | 0 | 1 |
NAD-dependent protein deacetylase sirtuin-1 | 0 | 1 | 0 | 1 |
P2Y purinoceptor 11 | 0 | 1 | 1 | 2 |
P2X purinoceptor 7 | 0 | 0 | 1 | 1 |
Protein arginine N-methyltransferase 1 | 0 | 1 | 0 | 1 |
P2Y purinoceptor 12 | 0 | 0 | 1 | 1 |
NAD-dependent protein deacylase sirtuin-5, mitochondrial | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |